IMS Health 10-Q 6 May 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2016	Apr. 29, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Trading Symbol	IMS
Entity Registrant Name	IMS Health Holdings, Inc.
Entity Central Index Key	1,595,262
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		329,877,234

Condensed Consolidated Statemen

Condensed Consolidated Statements of Financial Position - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Current Assets:
Cash and cash equivalents	$ 378	$ 396
Accounts receivable, net	585	508
Other current assets	187	188
Total Current Assets	1,150	1,092
Property, plant and equipment, at cost	326	314
Less accumulated depreciation	(158)	(147)
Property, plant and equipment, net	168	167
Computer software, net	323	309
Goodwill	3,844	3,604
Other identifiable intangibles, net	2,282	2,178
Other assets	128	109
Total Assets	7,895	7,459
Current Liabilities:
Accounts payable	128	163
Accrued and other current liabilities	562	611
Current portion of long-term debt	69	59
Deferred revenues	249	200
Total Current Liabilities	1,008	1,033
Postretirement and postemployment benefits	109	109
Long-term debt	4,468	4,136
Deferred tax liability	542	526
Other liabilities	90	83
Total Liabilities	$ 6,217	$ 5,887
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Common Stock, $0.01 par value, 700.0 shares authorized, 342.4 and 341.8 shares issued at March 31, 2016 and December 31, 2015, respectively	$ 3	$ 3
Capital in excess of par	2,039	2,038
Retained earnings	251	208
Treasury stock, at cost, 12.6 shares at March 31, 2016 and December 31, 2015, respectively	(328)	(327)
Accumulated other comprehensive loss	(287)	(350)
Total Stockholders’ Equity	1,678	1,572
Total Liabilities and Stockholders’ Equity	$ 7,895	$ 7,459

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Financial Position (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.01	$ 0.01
Common Stock, shares authorized	700,000,000	700,000,000
Common Stock, shares issued	342,400,000	341,800,000
Treasury stock, shares	12,600,000	12,600,000

Condensed Consolidated Stateme4

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Revenue	$ 774	$ 632
Information	376	354
Technology services	398	278
Operating costs of information, exclusive of depreciation and amortization	160	157
Direct and incremental costs of technology services, exclusive of depreciation and amortization	222	138
Selling and administrative expenses, exclusive of depreciation and amortization	177	137
Depreciation and amortization	87	96
Severance, impairment and other charges	15	13
Operating Income	113	91
Interest income	1
Interest expense	(46)	(37)
Other income (loss), net	(5)	4
Non-Operating Loss, Net	(50)	(33)
Income before income taxes	63	58
(Provision for) benefit from income taxes	(20)	240
Net Income	$ 43	$ 298
Earnings per Share Attributable to Common Stockholders:
Basic	$ 0.13	$ 0.89
Diluted	$ 0.13	$ 0.86
Weighted-Average Common Shares Outstanding:
Basic	328.6	335.5
Diluted	335.6	345.3
Comprehensive Income:
Net Income	$ 43	$ 298
Cumulative translation adjustment (net of taxes of $20 and $(48), respectively)	71	(77)
Unrealized (losses) gains on derivatives (net of taxes of $4 and $(1), respectively)	(7)	1
Gains on derivative instruments, reclassified into earnings (net of taxes of $1 and $2, respectively)	(1)	(4)
Other Comprehensive Income (Loss)	63	(80)
Total Comprehensive Income	$ 106	$ 218

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Other Comprehensive Income Loss Tax [Abstract]
Cumulative translation adjustment, taxes	$ 20	$ (48)
Unrealized (losses) gains on derivatives, taxes	4	(1)
(Gains) losses on derivative instruments, reclassified into earnings, taxes	$ 1	$ 2

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash Flows from Operating Activities:
Net Income	$ 43	$ 298
Adjustments to Reconcile Net Income (Loss) to Net Cash from Operating Activities:
Depreciation and amortization	87	96
Deferred income taxes	(4)	(262)
Non-cash stock-based compensation charges	7	6
Non-cash gains on derivative instruments	(9)	(1)
Non-cash amortization of debt original issue discount and issuance costs	3	2
Excess tax benefits from stock-based compensation		(11)
Other	(1)	8
Change in assets and liabilities, excluding effects from acquisitions and dispositions:
Net increase in current assets	(62)	(58)
Net decrease in current liabilities	(63)	(44)
Increase in pension assets (net of liabilities)	(4)	(6)
(Increase) decrease in other long-term assets (net of other long-term liabilities)	(12)	2
Net Cash (Used in) Provided by Operating Activities	(15)	30
Cash Flows from Investing Activities:
Capital expenditures	(13)	(9)
Additions to computer software	(26)	(23)
Payments for acquisitions of businesses, net of cash acquired	(252)	(26)
Other investing activities, net	1	(1)
Net Cash Used in Investing Activities	(290)	(59)
Cash Flows from Financing Activities:
Borrowings under revolving credit facility	172	97
Repayments of revolving credit facility	(158)	(106)
Proceeds from issuance of debt	300	296
Repayments of debt	(26)	(13)
Debt-related fees		(4)
Contingent consideration and deferred purchase price payments		(4)
Proceeds from equity plan activity	1	10
Payments for treasury stock	(3)
Excess tax benefits from stock-based compensation		11
Other financing activities	(6)
Net Cash Provided by Financing Activities	280	287
Effect of Exchange Rate Changes on Cash and Cash Equivalents	7	(9)
(Decrease) Increase in Cash and Cash Equivalents	(18)	249
Cash and Cash Equivalents, Beginning of Period	396	390
Cash and Cash Equivalents, End of Period	$ 378	$ 639

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock		Treasury Stock	Capital in Excess of Par	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2014	$ 1,542	$ 3		$ (10)	$ 1,975	$ (209)	$ (217)
Balance, shares at Dec. 31, 2014		335.6		(0.8)
Net Income	298					298
Issuances of common stock	11				11
Issuances of common stock, Shares		2
Stock-based compensation expense	6				6
Net tax benefit on stock-based compensation	11				11
Other comprehensive income (loss), net of tax	(80)						(80)
Balance at Mar. 31, 2015	1,788	$ 3		$ (10)	2,003	89	(297)
Balance, shares at Mar. 31, 2015		337.6		(0.8)
Balance at Dec. 31, 2015	1,572	$ 3		$ (327)	2,038	208	(350)
Balance, shares at Dec. 31, 2015		341.8	[1]	(12.6)
Net Income	43					43
Repurchases of common stock	(1)			$ (1)
Issuances of common stock and vesting of restricted stock	(6)				(6)
Issuances of common stock and vesting of restricted stock, Shares		0.6
Stock-based compensation expense	7				7
Other comprehensive income (loss), net of tax	63						63
Balance at Mar. 31, 2016	$ 1,678	$ 3		$ (328)	$ 2,039	$ 251	$ (287)
Balance, shares at Mar. 31, 2016		342.4		(12.6)
[1]	Shares of common stock at December 31, 2015 were revised to include 0.9 million restricted shares granted on December 31, 2015.

Condensed Consolidated Stateme8

Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) shares in Millions	12 Months Ended
	Dec. 31, 2015shares
Restricted Stock | Employees And Non Employee Directors
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Restricted shares granted	0.9

Basis of Presentation and Recen

Basis of Presentation and Recently Issued Accounting Standards	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation and Recently Issued Accounting Standards	Note 1. Basis of Presentation and Recently Issued Accounting Standards Background IMS Health Holdings, Inc. (the “Company”) is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. The Company has one of the largest and most comprehensive collections of healthcare information in the world, spanning sales, prescription and promotional data, medical claims, electronic medical records and social media. For information offerings, the Company receives data without patient identifiers and standardizes, organizes, structures and integrates this data by applying its sophisticated analytics and leveraging its global technology infrastructure to help its clients run their organizations more efficiently and make better decisions to improve their operational and financial performance. The Company has a presence in over 100 countries and generated 61% of its 2015 revenue from outside the United States. The Company serves key healthcare organizations and decision makers around the world, spanning the breadth of life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company’s information and technology services offerings, which it has developed with significant investment over its 60+ year history, are deeply integrated into its clients’ workflow. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. The Condensed Consolidated Financial Statements do not include all the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, all of which are of a normal recurring nature, considered necessary for a fair statement of financial position, results of operations and comprehensive income (loss), cash flows and stockholders’ equity for the periods presented have been included. The results of operations for interim periods are not necessarily indicative of the results expected for the full year. The December 31, 2015 Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. The Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and related notes of IMS Health Holdings, Inc. included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Certain prior year amounts have been reclassified to conform to the 2016 presentation. Amounts presented in the Condensed Consolidated Financial Statements may not add due to rounding. Recently Issued Accounting Standards In March 2016, the Financial Accounting Standards Board (“FASB”) issued guidance which simplifies certain aspects of accounting for share-based payments to employees, including the requirement for companies to recognize the income tax effects of awards in the income statement when the awards vest or are settled. Additionally, companies can elect to estimate forfeitures or recognize when they occur. The guidance is effective for the Company’s interim and annual periods beginning January 1, 2017. Earlier adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In May 2014, the FASB issued revised guidance on the recognition of revenue from contracts with customers. The guidance provides that revenue should be recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The guidance also requires enhanced disclosures. In August 2015, the FASB delayed the effective date of the guidance. In March 2016, the FASB issued further guidance on assessing whether an entity is a principal or an agent in a revenue transaction, which impacts whether an entity reports revenue on a gross or net basis. These revenue standards are effective for the Company’s interim and annual periods beginning January 1, 2018. Earlier adoption is permitted. The Company is currently evaluating the impact of these standards on its consolidated financial statements, as well as the method of transition it will use in adopting the new standards. In February 2016, the FASB issued updated guidance on leases. The guidance requires a lessee to recognize a right-of-use asset and a lease liability on the statement of financial position for all leases with terms more than 12 months. The new standard must be adopted using a modified retrospective transition approach, which requires application of the new guidance at the beginning of the earliest comparative period presented In May 2015, the FASB updated the accounting standards related to fair value measurement for investments that are measured at net asset value. The update eliminates the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share as a practical expedient. Adoption of this guidance on January 1, 2016 only impacts disclosures related to certain assets held by its pension plans and did not impact the Company’s consolidated financial results. In April 2015, the FASB issued guidance to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement. Under the new guidance, if a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. Adoption of this guidance on January 1, 2016, which is applied prospectively, did not have a material impact on our consolidated financial statements.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2016
Business Combinations [Abstract]
Acquisitions	Note 2. Acquisitions The Company makes acquisitions to enhance its capabilities and offerings in certain areas, including technology services. The Company completed four unrelated individually immaterial acquisitions during the first quarter of 2016. These acquisitions expanded the Company’s existing capabilities in technology services offerings, and to a lesser degree, information offerings. The purchase price allocations for these acquisitions will be finalized after the completion of the valuation of certain intangible assets and any adjustments to the preliminary purchase price allocation are not expected to have a material impact on the Company’s results of operations. The Condensed Consolidated Financial Statements include the results of the acquisitions subsequent to closing. As these acquisitions were immaterial to the Company’s operating results both individually and in the aggregate, pro forma results of operations are not provided. The following table provides certain financial information for these acquisitions, including the preliminary allocation of the aggregate purchase price to certain tangible and intangible assets acquired and goodwill. Amortization March 31, (in millions) Period 2016 Total cost of acquisitions, net of cash acquired $ 255 Acquisition-related costs 3 Amounts recorded in the Condensed Consolidated Statements of Financial Position: Goodwill $ 177 Portion of goodwill deductible for tax purposes — Computer software 5-10 years 18 Intangible assets: Client relationships 10 years $ 67 Databases 5 years 28 Trade names 10 years 4 Total intangible assets $ 99 Goodwill is attributable to the value of the synergies between the acquired companies and IMS Health. Cegedim Acquisition In April 2015, the Company completed the acquisition of certain customer relationship management (“CRM”) and strategic data businesses of Cegedim, SA (“Cegedim” and the “Cegedim acquisition”). Cegedim is a global technology and services company specializing in healthcare whose offerings help pharmaceutical companies manage their sales and marketing operations. The following pro forma information presents the financial results as if the acquisition of Cegedim had occurred on January 1, 2014, with pro forma adjustments to give effect to an increase in Selling and administrative expenses in 2014 for acquisition-related costs, additional depreciation and amortization for fair value adjustments of property, plant and equipment and intangible assets, an increase in interest expense from acquisition financing, and related tax effects. The pro forma results do not include any anticipated cost synergies, costs or other effects of the planned integration of Cegedim. Accordingly, such pro forma amounts are not necessarily indicative of the results that actually would have occurred for the period presented below had the Cegedim acquisition been completed on January 1, 2014, nor are they indicative of the future operating results of the Company. Three Months Ended March 31, 2015 (in millions) Revenues $ 750 Net income 300 Basic earnings per share 0.89 Diluted earnings per share 0.87 The Company has integrated Cegedim’s operations, and as such, computing a separate measure of Cegedim’s stand-alone revenue and profitability for the first quarter of 2016 is impracticable. Contingent Consideration Under the terms of certain acquisition-related purchase agreements, the Company may be required to pay additional amounts as contingent consideration based on the achievement of certain financial performance related metrics, ranging from $0 to $48 million through 2018. The Company’s contingent consideration recorded on the balance sheet was approximately $29 million and $28 million at March 31, 2016 and December 31, 2015, respectively. The fair value measurement of this contingent consideration is classified within Level 3 of the fair value hierarchy (see Note 5) and reflects the Company’s own assumptions in measuring fair values using the income approach. In developing these estimates, the Company considered certain performance projections, historical results, and industry trends. Changes in the fair value estimates are included in Selling and administrative expenses.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2016
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill	Note 3. Goodwill The following table sets forth changes in the Company’s goodwill for the three months ended March 31, 2016. (in millions) Goodwill Balance at December 31, 2015 $ 3,604 Goodwill assigned in purchase price allocations (see Note 2) 177 Foreign currency translation adjustments and other 63 Balance at March 31, 2016 $ 3,844

Severance, Impairment and Other

Severance, Impairment and Other Charges	3 Months Ended
	Mar. 31, 2016
Restructuring And Related Activities [Abstract]
Severance, Impairment and Other Charges	Note 4. Severance, Impairment and Other Charges As a result of ongoing cost reduction efforts, the Company recorded severance charges consisting of global workforce reductions to streamline its organization. The following table sets forth the activity in the Company’s severance-related reserves for the three months ended March 31, 2016: (in millions) 2016 Plan (1) 2015 Plan (2) Balance, December 31, 2015 $ — $ 51 Charges 15 — Cash payments (1 ) (17 ) Balance, March 31, 2016 $ 14 $ 34 (1) In the first quarter of 2016, the Company implemented a restructuring plan (the “2016 Plan”) and recorded a pre-tax severance charge of $15 million. The Company expects that cash outlays related to the 2016 Plan will be substantially complete by the end of 2018. (2) In the first quarter of 2015, the Company implemented a restructuring plan (the “2015 Plan”) and recorded a pre-tax severance charge of $12 million. An additional $64 million was recorded over the remainder of 2015. The Company expects that cash outlays related to the 2015 Plan will be substantially complete by the end of 2017.

Derivatives and Fair Value

Derivatives and Fair Value	3 Months Ended
	Mar. 31, 2016
Derivatives And Fair Value Disclosure [Abstract]
Derivatives and Fair Value	Note 5. Derivatives and Fair Value Foreign Exchange Risk Management The Company transacts business in more than 100 countries and is subject to risks associated with fluctuating foreign exchange rates. The Company’s objective is to reduce earnings and cash flow volatility associated with foreign exchange rate movements. Accordingly, the Company enters into foreign currency forward contracts to minimize the impact of foreign exchange movements on non–functional currency assets and liabilities The forward contracts entered into for balance sheet risk management purposes are not designated as hedges and are carried at fair value, with changes in the fair value recorded to Other income (loss), net in the Condensed Consolidated Statements of Comprehensive Income (Loss). These contracts do not subject the Company to material balance sheet risk because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. The forward contracts entered into for Royalty Hedging purposes are designated as hedges and are carried at fair value, with changes in the fair value recorded to The following table details the components of foreign exchange gain (loss) included in Other income (loss), net on the Condensed Consolidated Statements of Comprehensive Income (Loss): Three Months Ended (in millions) 2016 2015 Revaluation of other non-functional currency assets and liabilities (1) $ (7 ) $ — Effect of derivatives 3 4 Total foreign exchange gain (loss) $ (4 ) $ 4 (1) Bolívar Net Investment Risk Management The Company designates its foreign currency denominated debt as a hedge of its net investment in foreign subsidiaries to reduce the volatility in stockholders’ equity caused by changes in the Euro exchange rate with respect to the U.S. Dollar. As of March 31, 2016, these borrowings (net of original issue discount) were €1,123 million ($1,279 million). The effective portion of foreign exchange gains or losses on the remeasurement of the debt is recognized in the cumulative translation adjustment component of AOCI with the related offset in long-term debt. Those amounts would be reclassified from AOCI to earnings upon the sale or substantial liquidation of these net investments. The amount of foreign exchange (losses) gains related to the net investment hedge included in cumulative translation adjustment for the three months ended March 31, 2016 and 2015 were $(52) million and $122 million, respectively. Interest Rate Risk Management The Company purchases interest rate caps and has entered into interest rate swap agreements for purposes of managing its risk in interest rate fluctuations. In 2014, the Company purchased U.S. Dollar denominated interest rate caps (“2014 Caps”) at strike rates ranging between 2% and 3%. These caps are effective at various times through April 2016, and expire at various times between April 2017 and April 2019. The 2014 Caps are designated as cash flow hedges. The Company also entered into U.S. Dollar and Euro denominated interest rate swap agreements in 2014 (“2014 Swaps”) to hedge interest rate exposure on its borrowings. The 2014 swaps expire at various times from March 2017 through March 2021. On these agreements, the Company pays a fixed rate ranging from 1.4% to 2.1% and receives a variable rate of interest equal to the greater of three-month U.S. Dollar London Interbank Offered Rate (“LIBOR”) or three-month Euro Interbank Offered Rate (“EURIBOR”), and 1%. The 2014 Swaps are designated as cash flow hedges. The Company also entered into interest rate swap agreements in 2010 (“2010 Swaps”) to hedge interest rate exposure on its borrowings. The 2010 Swaps expired at various times through January 2016. On these agreements, the Company paid a fixed rate ranging from 3% to 3.3% and received a variable rate of interest equal to the three-month LIBOR. The 2010 Swaps were not designated as cash flow hedges. The fair values of derivative instruments in the Condensed Consolidated Statements of Financial Position are as follows: March 31, 2016 December 31, 2015 Fair Value of Derivative U.S. Dollar Notional Fair Value of Derivative U.S. Dollar Notional (in millions) Balance Sheet Caption Asset Liability Asset Liability Derivatives Designated as Hedging Instruments: Foreign exchange contracts Accounts receivable/ Accounts payable $ 1 $ 8 $ 180 $ 4 $ 2 $ 178 Interest rate caps Non-Current Assets 1 — 1,000 4 — 1,000 Interest rate swaps See below (1) — 13 530 — 10 517 Derivatives not Designated as Hedging Instruments: Foreign exchange contracts Accounts receivable/ Accounts payable 3 — 150 3 — 148 Interest rate swaps See below (1) — — — — 1 100 Total Derivatives $ 5 $ 21 $ 11 $ 13 (1) $13 million included in Other liabilities at March 31, 2016 and $1 million included in Accrued and other current liabilities and $10 million included in Other liabilities at December 31, 2015 in the Condensed Consolidated Statements of Financial Position. For derivatives designated as hedges, the Company assesses, both at the inception of the hedge and on an ongoing basis, whether the derivatives are highly effective in offsetting changes in fair values or cash flows of hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, the Company will discontinue hedge accounting with respect to that derivative prospectively. When it is probable that a hedged forecasted transaction will not occur, the Company discontinues hedge accounting for the affected portion of the forecasted transaction, and reclassifies gains or losses that were accumulated in AOCI to earnings in Other income (loss), net for foreign exchange derivatives and interest expense for interest rate derivatives on the Condensed Consolidated Statements of Comprehensive Income (Loss). Cash flows are classified consistent with the underlying hedged item. The effects of derivative instruments in cash flow hedging relationships on the Condensed Consolidated Statements of Comprehensive Income (Loss) are as follows: (in millions) Effect of Derivatives on Financial Performance Amount of Income/(Loss) Location of Income/(Loss) Amount of Three Months Ended March 31, 2016 2015 2016 2015 Foreign exchange contracts $ (8 ) $ 7 Other income (loss), net $ 2 $ 6 Interest rate derivatives (4 ) (4 ) Interest expense — — The pre-tax gain (loss) recognized in other income (loss), net for foreign exchange contracts not designated as hedging instruments was $1 million and $(2) million for the first quarter of 2016 and 2015, respectively. Changes in the fair value of derivatives that are designated as cash flow hedges are recorded in AOCI to the extent effective and reclassified into earnings in the same period or periods during which the transaction hedged by that derivative also affects earnings. The Company expects $15 million of pre-tax unrealized losses related to its foreign exchange contracts and interest rate derivatives included in AOCI at March 31, 2016 to be reclassified into earnings within the next twelve months. Fair Value Disclosures The Company is subject to authoritative guidance which requires a three-level hierarchy for disclosure of fair value measurements as follows: Level 1 — Quoted prices in active markets for identical assets or liabilities. Level 2 — Quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets; and model-derived valuations in which all significant inputs are observable in active markets. Level 3 — Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. The carrying values of cash, cash equivalents, restricted cash, accounts receivable and accounts payable approximated their fair values at March 31, 2016 and December 31, 2015 due to the short-term nature of these instruments. At March 31, 2016 and December 31, 2015, the fair value of total debt approximated $4,613 million and $4,229 million, respectively, as determined under Level 2 measurements based on quoted prices for these financial instruments. Recurring Measurements The following tables summarize assets and liabilities measured at fair value on a recurring basis at the dates indicated: Basis of Fair Value Measurements March 31, 2016 (in millions) Level 1 Level 2 Level 3 Total Assets Derivatives $ — $ 5 — $ 5 Total $ — $ 5 $ — $ 5 Liabilities Contingent consideration $ — $ — $ 29 $ 29 Derivatives — 21 — 21 Total $ — $ 21 $ 29 $ 50 December 31, 2015 Level 1 Level 2 Level 3 Total Assets Derivatives $ — $ 11 $ — $ 11 Total $ — $ 11 $ — $ 11 Liabilities Contingent consideration $ — $ — $ 28 $ 28 Derivatives — 13 — 13 Total $ — $ 13 $ 28 $ 41 Derivatives consist of foreign exchange contracts and interest rate caps and swaps. The fair value of foreign exchange contracts is based on observable market inputs of spot and forward rates. The fair value of the interest rate caps and swaps is the estimated amount that the Company would receive or pay to terminate such agreements, taking into account market interest rates and the remaining time to maturities. The following table summarizes Level 3 acquisition-related contingent consideration liabilities (see Note 2) carried at fair value on a recurring basis with the use of unobservable inputs for the period indicated. (in millions) Contingent Balance at December 31, 2015 $ 28 New acquisitions 2 Changes in fair value estimates and foreign currency translation adjustments (1 ) Balance at March 31, 2016 $ 29

Debt

Debt	3 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Debt	Note 6. Debt The following table summarizes the Company’s debt at the dates indicated: March 31, December 31, (in millions) 2016 2015 Senior Secured Credit Facilities: Senior Secured Term A Loan due 2019—USD LIBOR at average floating rates of 2.88% $ 766 $ 484 Senior Secured Term A Loan due 2019—EUR LIBOR at average floating rates of 2.25% 139 135 Senior Secured Term B Loan due 2021—USD LIBOR at average floating rates of 3.50% 1,713 1,717 Senior Secured Term B Loan due 2021—EUR LIBOR at average floating rates of 3.75% 833 802 Revolving Credit Facility due 2019: U.S. Dollar denominated borrowings—USD LIBOR at average floating rates of 2.80% 342 328 4.125% Senior Notes due 2023 - Euro denominated 313 300 6.00% Senior Notes due 2020 - U.S. Dollar denominated 500 500 Principal Amount of Debt 4,606 4,266 Less: Debt Issuance Costs and Unamortized Discounts (69 ) (71 ) Total Debt $ 4,537 $ 4,195 Scheduled principal payments due on the Company’s debt as of March 31, 2016 for the remainder of 2016 and thereafter were as follows: Year (in millions) 2016 2017 2018 2019 2020 Thereafter Total Debt $ 50 $ 95 $ 120 $ 1,080 $ 526 $ 2,735 $ 4,606 Senior Secured Credit Facilities In January 2016, IMS Health Incorporated (“IMS Health”), an indirect wholly owned subsidiary of the Company, entered into an amendment (the “2016 Amendment”) to the Third Amended and Restated Credit and Guaranty Agreement, dated as of March 17, 2014, among IMS Health, IMS AG and IMS Japan K.K., as co-borrowers, Healthcare Technology Intermediate Holdings, Inc., Bank of America, N.A. and the other lenders party thereto. The 2016 Amendment increased outstanding commitments under the Company’s existing Term A loans by $300 million. The proceeds from the additional Term A loans were used for general corporate purposes, including funding acquisitions and repaying existing loans under IMS Health’s senior secured revolving credit facility. As a result of the 2016 Amendment, the Company incurred $2 million of fees; of which $1 million was recorded in Other income (loss), net during the first quarter of 2016 and $1 million will be amortized to interest expense. At March 31, 2016, the Company had an aggregate $500 million revolving credit facility, of which $158 million was unused.

Pension and Postretirement Bene

Pension and Postretirement Benefits	3 Months Ended
	Mar. 31, 2016
Compensation And Retirement Disclosure [Abstract]
Pension and Postretirement Benefits	Note 7. Pension and Postretirement Benefits The following table summarizes the components of net periodic benefit cost for the Company’s pension benefits. Pension Benefits U.S. Plans Non-U.S. Plans Three Months Ended March 31, (in millions) 2016 2015 2016 2015 Service cost $ 3 $ 3 $ 2 $ 2 Interest cost 3 3 2 2 Expected return on plan assets (6 ) (6 ) (3 ) (3 ) Net periodic benefit cost $ — $ — $ 1 $ 1 The Company’s net periodic benefit credit for its postretirement benefits was less than $1 million for the three months ended March 31, 2016 and 2015, respectively. During the three months ended March 31, 2016, the Company contributed approximately $6 million to its pension and postretirement benefit plans and expects to contribute an additional $5 million for the remainder of 2016.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2016
Equity [Abstract]
Stockholders' Equity	Note 8. Stockholders’ Equity Share Repurchase On December 16, 2015, the Company’s board of directors approved a $250 million common stock repurchase authorization. Through December 31, 2015, the Company had purchased 670 thousand shares of its common stock having an aggregate value of approximately $17 million at an average price of $25.70 per share. There were no share repurchases in the first quarter of 2016 under this authorization; however, the Company paid $3 million in the first quarter of 2016 for the settlement of certain repurchases that occurred in the fourth quarter of 2015. The share repurchase was funded through a combination of cash and borrowings under the Company’s revolving credit facility. The repurchase authorization does not have a specified expiration date but can be modified, suspended or discontinued at any time.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2016
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	Note 9. Accumulated Other Comprehensive Income (Loss) The following table summarizes the changes in the components of AOCI, net of tax, for the periods indicated: (in millions) Cumulative Translation Adjustment Unrealized Gains (Losses) on Derivative Instruments Unamortized Pension and Other Benefits Adjustment Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2015 $ (287 ) $ (15 ) $ (48 ) $ (350 ) Other comprehensive income (loss) before reclassifications 71 (7 ) — 64 Amounts reclassified into earnings — (1 ) — (1 ) Other comprehensive income (loss) 71 (8 ) — 63 Balance, March 31, 2016 $ (216 ) $ (23 ) $ (48 ) $ (287 ) (in millions) Cumulative Translation Adjustment Unrealized Gains (Losses) on Derivative Instruments Unamortized Pension and Other Benefits Adjustment Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2014 $ (169 ) $ (1 ) $ (47 ) $ (217 ) Other comprehensive income (loss) before reclassifications (77 ) 1 — (76 ) Amounts reclassified into earnings — (4 ) — (4 ) Other comprehensive income (loss) (77 ) (3 ) — (80 ) Balance, March 31, 2015 $ (246 ) $ (4 ) $ (47 ) $ (297 )

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Note 10. Income Taxes The Company operates in more than 100 countries around the world and its earnings are taxed at the applicable income tax rate in each of these countries. As required, the Company computes interim taxes based on an estimated annual effective tax rate. The Company recorded a provision for income taxes of $20 million for the three months ended March 31, 2016. The tax expense was favorably impacted as a result of profits generated in non-U.S. tax jurisdictions with lower tax rates than the U.S. statutory tax rate. The Company recorded a benefit for income taxes of $240 million for the three months ended March 31, 2015, primarily due to the Company changing its assertion related to unremitted earnings of its non-U.S. subsidiaries. Historically, the Company provided deferred taxes with respect to all of the unremitted earnings of its non-U.S. subsidiaries. As of the beginning of 2015, the Company began asserting, with certain exceptions, that the unremitted earnings of its non-U.S. subsidiaries will be indefinitely reinvested. As a result of this change in assertion, the Company reversed a previously established deferred tax liability of $256 million as a discrete benefit to the quarter.

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2016
Commitments And Contingencies Disclosure [Abstract]
Contingencies	Note 11. Contingencies The Company and its subsidiaries are involved in legal and tax proceedings, claims and litigation arising in the ordinary course of business. Management periodically assesses the Company’s liabilities and contingencies in connection with these matters based upon the latest information available. For those matters where management currently believes it is probable that the Company will incur a loss and that the probable loss or range of loss can be reasonably estimated, the Company has recorded reserves in the Condensed Consolidated Financial Statements based on its best estimates of such loss. In other instances, because of the uncertainties related to either the probable outcome or the amount or range of loss, management is unable to make a reasonable estimate of a liability, if any. However, even in many instances where the Company has recorded an estimated liability, the Company is unable to predict with certainty the final outcome of the matter or whether resolution of the matter will materially affect the Company’s results of operations, financial position or cash flows. As additional information becomes available, the Company adjusts its assessments and estimates of such liabilities accordingly. The Company routinely enters into agreements with its suppliers to acquire data and with its clients to sell data, all in the normal course of business. In these agreements, the Company sometimes agrees to indemnify and hold harmless the other party for any damages such other party may suffer as a result of potential intellectual property infringement and other claims related to the use of the data. The Company has not accrued a liability with respect to these matters, as the exposure is considered remote. Based on its review of the latest information available, management does not expect the impact of pending legal and tax proceedings, claims and litigation, either individually or in the aggregate, to have a material adverse effect on the Company’s results of operations, cash flows or financial position. However, one or more unfavorable outcomes in any claim or litigation against the Company could have a material adverse effect for the period in which it is resolved. The following is a summary of certain legal matters involving the Company. IMS Health Government Solutions Voluntary Disclosure Program Participation The Company’s wholly-owned subsidiary, IMS Government Solutions Inc. (“IMS Government Solutions”), is primarily engaged in providing services and products under contracts with the U.S. government. U.S. government contracts are subject to extensive legal and regulatory requirements and, from time to time, agencies of the U.S. government have the ability to investigate whether contractors’ operations are being conducted in accordance with such requirements. U.S. government investigations, whether relating to these contracts or conducted for other reasons, could result in administrative, civil or criminal liabilities, including repayments, fines or penalties being imposed on us, or could lead to suspension or debarment from future U.S. government contracting. U.S. government investigations often take years to complete and may result in no adverse action against the Company. IMS Government Solutions discovered potential noncompliance with various contract clauses and requirements under its General Services Administration Contract (the “GSA Contract”) which was awarded in 2002 to its predecessor company, Synchronous Knowledge Inc. (Synchronous Knowledge Inc. was acquired by IMS Health in May 2005). The potential noncompliance arose from three primary areas: first, at the direction of the government, work performed under one task order was invoiced under another task order without the appropriate modifications to the orders being made; second, personnel who did not meet strict compliance with the labor categories component of the qualification requirements of the GSA Contract were assigned to contracts; and third, certain discounts that were given to commercial customers were not also offered to the government, in alleged violation of the GSA Contract’s Price Reductions Clause. Upon discovery of the potential noncompliance, the Company began remediation efforts, promptly disclosed the potential noncompliance to the U.S. government, and was accepted into the Department of Defense Voluntary Disclosure Program. The Company filed its Voluntary Disclosure Program Report (“Disclosure Report”) on August 29, 2008. Based on the Company’s findings as disclosed in the Disclosure Report, the Company recorded a reserve of approximately $4 million for this matter in 2008. During 2010, the Company recorded an additional reserve of approximately $2 million as a result of its ongoing investigation relating to this matter. In September 2014, the General Services Administration offered to settle the third matter described above (i.e., the Price Reductions Clause aspect of the Disclosure Report) for $1.5 million, in-line with the amount the Company had recorded for this area of potential noncompliance. On April 23, 2015, the Company and the government executed the settlement agreement and made the $1.5 million payment. The Company is currently unable to determine the outcome of the remaining matters pending the resolution of the Voluntary Disclosure Program process and its ultimate liability arising from these matters could exceed its current reserves. Symphony Health Solutions Litigation On July 24, 2013, Symphony Health Solutions and two of its subsidiaries (collectively “Symphony”) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania against IMS Health alleging anticompetitive business practices in violation of the Sherman Antitrust Act and Pennsylvania State law. IMS Health asserted various counterclaims in that lawsuit. On December 20, 2013, IMS Health filed a lawsuit in the U.S. District Court for the District of Delaware against Symphony for infringement of three patents seeking injunctive relief and damages. In late 2015, the Company and Symphony entered into a settlement agreement whereby each of the parties agreed to terminate their respective lawsuits, and these lawsuits were dismissed with prejudice in January, 2016.

Operations by Business Segment

Operations by Business Segment	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Operations by Business Segment	Note 12. Operations by Business Segment Operating segments are defined as components of an enterprise about which financial information is available that is evaluated on a regular basis by the chief operating decision-maker, or decision-making groups, in deciding how to allocate resources to an individual segment and in assessing performance of the segment. The Company operates a globally consistent business model, offering clients in the healthcare industry with comprehensive solutions to measure and improve their performance. The Company maintains regional geographic management who are responsible for bringing the Company’s full suite of offerings to their respective markets and to facilitate local execution of its global strategies. However, the Company maintains global leaders for the majority of its critical business processes; and the most significant performance evaluations and resource allocations made by the Company’s chief operating decision maker is made on a global basis. As such, the Company has concluded that it maintains one operating and reportable segment. Geographic Financial Information: The following represents selected geographic information for the regions in which the Company operates. (in millions) Americas (1) EMEA (2) Asia Pacific (3) Corporate & Other Total Three Months Ended March 31, 2016 Revenue (4) $ 353 $ 307 $ 114 $ — $ 774 Operating income (loss) (5) 45 66 35 (33 ) 113 2015 Revenue (4) $ 294 $ 231 $ 107 $ — $ 632 Operating income (loss) (5) 67 58 39 (73 ) 91 In April 2015, the Company realigned its regional reporting so that India, Sri Lanka and Bangladesh are included in EMEA. Previously, these countries had been included in the Asia Pacific region. Additionally in 2015, the Company made changes to its geographic reporting classifications to move some functions out of Corporate and Other and into the regions. As a result of these changes, reclassifications of prior years’ geographic financial information were made to conform to the current year presentation. The reclassifications did not change previously reported condensed consolidated results of operations. (1) (2) (3) (4) (5) (in millions) Americas EMEA Asia Pacific Three Months Ended March 31, 2016 18 4 6 2015 27 14 8

Earnings per Share

Earnings per Share	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Earnings per Share	Note 13. Earnings per Share Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed, when the result is dilutive, using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of employee stock options and restricted stock units. Employee stock options, restricted stock units and similar equity instruments granted by the Company are treated as potential common shares outstanding in computing diluted earnings per share. Diluted shares outstanding include restricted stock units and the dilutive effect of in-the-money options which is calculated based on the average share price for each fiscal period using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of benefits that would be recorded in additional paid-in capital when the award becomes deductible for tax purposes are assumed to be used to repurchase shares. In periods of net loss, basic loss per share and diluted loss per share are the same since the effect of potential common shares is anti-dilutive and therefore excluded. The following table presents the composition of basic and diluted weighted average shares outstanding: Three Months Ended (Shares in millions) 2016 2015 Basic weighted-average common shares outstanding 328.6 335.5 Effect of dilutive stock-based awards 7.0 9.8 Diluted weighted-average common shares outstanding 335.6 345.3 Shares excluded from computation of diluted earnings per share: Weighted average potential common shares excluded from computation due to anti-dilutive effect 3.7 —

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 14. Subsequent Events On May 3, 2016, the Company and Quintiles Transnational Holdings Inc. (“Quintiles”) entered into a definitive merger agreement, pursuant to which the companies will be combined. The merged company will be renamed Quintiles IMS Holdings, Inc. Under the terms of the merger agreement, the Company’s shareholders will receive 0.3840 shares of Quintiles common stock for each share of IMS common stock. Upon completion of the merger, the Company’s shareholders will own approximately 51.4 percent of the shares of the combined company on a fully diluted basis and Quintiles shareholders will own approximately 48.6 percent of the combined company on a fully diluted basis. The transaction is subject to customary closing conditions, including regulatory approvals and approval by both IMS and Quintiles shareholders, and is expected to close in the second half of 2016.

Basis of Presentation and Rec23

Basis of Presentation and Recently Issued Accounting Standards (Policies)	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. The Condensed Consolidated Financial Statements do not include all the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments, all of which are of a normal recurring nature, considered necessary for a fair statement of financial position, results of operations and comprehensive income (loss), cash flows and stockholders’ equity for the periods presented have been included. The results of operations for interim periods are not necessarily indicative of the results expected for the full year. The December 31, 2015 Condensed Consolidated Statement of Financial Position was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. The Condensed Consolidated Financial Statements and related notes should be read in conjunction with the audited Consolidated Financial Statements and related notes of IMS Health Holdings, Inc. included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Certain prior year amounts have been reclassified to conform to the 2016 presentation. Amounts presented in the Condensed Consolidated Financial Statements may not add due to rounding.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In March 2016, the Financial Accounting Standards Board (“FASB”) issued guidance which simplifies certain aspects of accounting for share-based payments to employees, including the requirement for companies to recognize the income tax effects of awards in the income statement when the awards vest or are settled. Additionally, companies can elect to estimate forfeitures or recognize when they occur. The guidance is effective for the Company’s interim and annual periods beginning January 1, 2017. Earlier adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements. In May 2014, the FASB issued revised guidance on the recognition of revenue from contracts with customers. The guidance provides that revenue should be recognized for the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The guidance also requires enhanced disclosures. In August 2015, the FASB delayed the effective date of the guidance. In March 2016, the FASB issued further guidance on assessing whether an entity is a principal or an agent in a revenue transaction, which impacts whether an entity reports revenue on a gross or net basis. These revenue standards are effective for the Company’s interim and annual periods beginning January 1, 2018. Earlier adoption is permitted. The Company is currently evaluating the impact of these standards on its consolidated financial statements, as well as the method of transition it will use in adopting the new standards. In February 2016, the FASB issued updated guidance on leases. The guidance requires a lessee to recognize a right-of-use asset and a lease liability on the statement of financial position for all leases with terms more than 12 months. The new standard must be adopted using a modified retrospective transition approach, which requires application of the new guidance at the beginning of the earliest comparative period presented In May 2015, the FASB updated the accounting standards related to fair value measurement for investments that are measured at net asset value. The update eliminates the requirement to categorize within the fair value hierarchy all investments for which fair value is measured using the net asset value per share as a practical expedient. Adoption of this guidance on January 1, 2016 only impacts disclosures related to certain assets held by its pension plans and did not impact the Company’s consolidated financial results. In April 2015, the FASB issued guidance to help entities evaluate the accounting for fees paid by a customer in a cloud computing arrangement. Under the new guidance, if a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. Adoption of this guidance on January 1, 2016, which is applied prospectively, did not have a material impact on our consolidated financial statements.
Derivatives	The forward contracts entered into for balance sheet risk management purposes are not designated as hedges and are carried at fair value, with changes in the fair value recorded to Other income (loss), net in the Condensed Consolidated Statements of Comprehensive Income (Loss). The forward contracts entered into for Royalty Hedging purposes are designated as hedges and are carried at fair value, with changes in the fair value recorded to The effective portion of foreign exchange gains or losses on the remeasurement of the debt is recognized in the cumulative translation adjustment component of AOCI with the related offset in long-term debt. Those amounts would be reclassified from AOCI to earnings upon the sale or substantial liquidation of these net investments. For derivatives designated as hedges, the Company assesses, both at the inception of the hedge and on an ongoing basis, whether the derivatives are highly effective in offsetting changes in fair values or cash flows of hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, the Company will discontinue hedge accounting with respect to that derivative prospectively. When it is probable that a hedged forecasted transaction will not occur, the Company discontinues hedge accounting for the affected portion of the forecasted transaction, and reclassifies gains or losses that were accumulated in AOCI to earnings in Other income (loss), net for foreign exchange derivatives and interest expense for interest rate derivatives on the Condensed Consolidated Statements of Comprehensive Income (Loss). Cash flows are classified consistent with the underlying hedged item. Changes in the fair value of derivatives that are designated as cash flow hedges are recorded in AOCI to the extent effective and reclassified into earnings in the same period or periods during which the transaction hedged by that derivative also affects earnings.
Income Taxes	As required, the Company computes interim taxes based on an estimated annual effective tax rate.
Contingencies	For those matters where management currently believes it is probable that the Company will incur a loss and that the probable loss or range of loss can be reasonably estimated, the Company has recorded reserves in the Condensed Consolidated Financial Statements based on its best estimates of such loss. In other instances, because of the uncertainties related to either the probable outcome or the amount or range of loss, management is unable to make a reasonable estimate of a liability, if any. However, even in many instances where the Company has recorded an estimated liability, the Company is unable to predict with certainty the final outcome of the matter or whether resolution of the matter will materially affect the Company’s results of operations, financial position or cash flows. As additional information becomes available, the Company adjusts its assessments and estimates of such liabilities accordingly.
Computation of Earnings per Share	Basic earnings (loss) per share is computed using the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share is computed, when the result is dilutive, using the weighted-average number of common shares and dilutive potential common shares outstanding during the period. Dilutive potential common shares primarily consist of employee stock options and restricted stock units. Employee stock options, restricted stock units and similar equity instruments granted by the Company are treated as potential common shares outstanding in computing diluted earnings per share. Diluted shares outstanding include restricted stock units and the dilutive effect of in-the-money options which is calculated based on the average share price for each fiscal period using the treasury stock method. Under the treasury stock method, the amount the employee must pay for exercising stock options, the amount of compensation cost for future service that the Company has not yet recognized, and the amount of benefits that would be recorded in additional paid-in capital when the award becomes deductible for tax purposes are assumed to be used to repurchase shares. In periods of net loss, basic loss per share and diluted loss per share are the same since the effect of potential common shares is anti-dilutive and therefore excluded.

Acquisitions (Tables)

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2016
Business Acquisition [Line Items]
Schedule of Financial Information Related to Acquisitions	The following table provides certain financial information for these acquisitions, including the preliminary allocation of the aggregate purchase price to certain tangible and intangible assets acquired and goodwill. Amortization March 31, (in millions) Period 2016 Total cost of acquisitions, net of cash acquired $ 255 Acquisition-related costs 3 Amounts recorded in the Condensed Consolidated Statements of Financial Position: Goodwill $ 177 Portion of goodwill deductible for tax purposes — Computer software 5-10 years 18 Intangible assets: Client relationships 10 years $ 67 Databases 5 years 28 Trade names 10 years 4 Total intangible assets $ 99
Cegedim Acquisition
Business Acquisition [Line Items]
Schedule of Pro Forma Information	The following pro forma information presents the financial results as if the acquisition of Cegedim had occurred on January 1, 2014, with pro forma adjustments to give effect to an increase in Selling and administrative expenses in 2014 for acquisition-related costs, additional depreciation and amortization for fair value adjustments of property, plant and equipment and intangible assets, an increase in interest expense from acquisition financing, and related tax effects. The pro forma results do not include any anticipated cost synergies, costs or other effects of the planned integration of Cegedim. Accordingly, such pro forma amounts are not necessarily indicative of the results that actually would have occurred for the period presented below had the Cegedim acquisition been completed on January 1, 2014, nor are they indicative of the future operating results of the Company. Three Months Ended March 31, 2015 (in millions) Revenues $ 750 Net income 300 Basic earnings per share 0.89 Diluted earnings per share 0.87

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2016
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes in Goodwill	The following table sets forth changes in the Company’s goodwill for the three months ended March 31, 2016. (in millions) Goodwill Balance at December 31, 2015 $ 3,604 Goodwill assigned in purchase price allocations (see Note 2) 177 Foreign currency translation adjustments and other 63 Balance at March 31, 2016 $ 3,844

Severance, Impairment and Oth26

Severance, Impairment and Other Charges (Tables)	3 Months Ended
	Mar. 31, 2016
Restructuring And Related Activities [Abstract]
Schedule of Severance Related Reserves	As a result of ongoing cost reduction efforts, the Company recorded severance charges consisting of global workforce reductions to streamline its organization. The following table sets forth the activity in the Company’s severance-related reserves for the three months ended March 31, 2016: (in millions) 2016 Plan (1) 2015 Plan (2) Balance, December 31, 2015 $ — $ 51 Charges 15 — Cash payments (1 ) (17 ) Balance, March 31, 2016 $ 14 $ 34 (1) In the first quarter of 2016, the Company implemented a restructuring plan (the “2016 Plan”) and recorded a pre-tax severance charge of $15 million. The Company expects that cash outlays related to the 2016 Plan will be substantially complete by the end of 2018. (2) In the first quarter of 2015, the Company implemented a restructuring plan (the “2015 Plan”) and recorded a pre-tax severance charge of $12 million. An additional $64 million was recorded over the remainder of 2015. The Company expects that cash outlays related to the 2015 Plan will be substantially complete by the end of 2017.

Derivatives and Fair Value (Tab

Derivatives and Fair Value (Tables)	3 Months Ended
	Mar. 31, 2016
Derivatives And Fair Value Disclosure [Abstract]
Schedule of Components of Foreign Exchange Gain (loss)	The following table details the components of foreign exchange gain (loss) included in Other income (loss), net on the Condensed Consolidated Statements of Comprehensive Income (Loss): Three Months Ended (in millions) 2016 2015 Revaluation of other non-functional currency assets and liabilities (1) $ (7 ) $ — Effect of derivatives 3 4 Total foreign exchange gain (loss) $ (4 ) $ 4 (1) Bolívar
Schedule of Fair Value of Derivative Instruments	The fair values of derivative instruments in the Condensed Consolidated Statements of Financial Position are as follows: March 31, 2016 December 31, 2015 Fair Value of Derivative U.S. Dollar Notional Fair Value of Derivative U.S. Dollar Notional (in millions) Balance Sheet Caption Asset Liability Asset Liability Derivatives Designated as Hedging Instruments: Foreign exchange contracts Accounts receivable/ Accounts payable $ 1 $ 8 $ 180 $ 4 $ 2 $ 178 Interest rate caps Non-Current Assets 1 — 1,000 4 — 1,000 Interest rate swaps See below (1) — 13 530 — 10 517 Derivatives not Designated as Hedging Instruments: Foreign exchange contracts Accounts receivable/ Accounts payable 3 — 150 3 — 148 Interest rate swaps See below (1) — — — — 1 100 Total Derivatives $ 5 $ 21 $ 11 $ 13 (1) $13 million included in Other liabilities at March 31, 2016 and $1 million included in Accrued and other current liabilities and $10 million included in Other liabilities at December 31, 2015 in the Condensed Consolidated Statements of Financial Position.
Schedule of Effect of Derivatives on Financial Performance	The effects of derivative instruments in cash flow hedging relationships on the Condensed Consolidated Statements of Comprehensive Income (Loss) are as follows: (in millions) Effect of Derivatives on Financial Performance Amount of Income/(Loss) Location of Income/(Loss) Amount of Three Months Ended March 31, 2016 2015 2016 2015 Foreign exchange contracts $ (8 ) $ 7 Other income (loss), net $ 2 $ 6 Interest rate derivatives (4 ) (4 ) Interest expense — —
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following tables summarize assets and liabilities measured at fair value on a recurring basis at the dates indicated: Basis of Fair Value Measurements March 31, 2016 (in millions) Level 1 Level 2 Level 3 Total Assets Derivatives $ — $ 5 — $ 5 Total $ — $ 5 $ — $ 5 Liabilities Contingent consideration $ — $ — $ 29 $ 29 Derivatives — 21 — 21 Total $ — $ 21 $ 29 $ 50 December 31, 2015 Level 1 Level 2 Level 3 Total Assets Derivatives $ — $ 11 $ — $ 11 Total $ — $ 11 $ — $ 11 Liabilities Contingent consideration $ — $ — $ 28 $ 28 Derivatives — 13 — 13 Total $ — $ 13 $ 28 $ 41
Schedule of Level 3 Acquisition-Related Contingent Consideration Liabilities Carried at Fair Value on a Recurring Basis	The following table summarizes Level 3 acquisition-related contingent consideration liabilities (see Note 2) carried at fair value on a recurring basis with the use of unobservable inputs for the period indicated. (in millions) Contingent Balance at December 31, 2015 $ 28 New acquisitions 2 Changes in fair value estimates and foreign currency translation adjustments (1 ) Balance at March 31, 2016 $ 29

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2016
Debt Disclosure [Abstract]
Schedule of Debt	The following table summarizes the Company’s debt at the dates indicated: March 31, December 31, (in millions) 2016 2015 Senior Secured Credit Facilities: Senior Secured Term A Loan due 2019—USD LIBOR at average floating rates of 2.88% $ 766 $ 484 Senior Secured Term A Loan due 2019—EUR LIBOR at average floating rates of 2.25% 139 135 Senior Secured Term B Loan due 2021—USD LIBOR at average floating rates of 3.50% 1,713 1,717 Senior Secured Term B Loan due 2021—EUR LIBOR at average floating rates of 3.75% 833 802 Revolving Credit Facility due 2019: U.S. Dollar denominated borrowings—USD LIBOR at average floating rates of 2.80% 342 328 4.125% Senior Notes due 2023 - Euro denominated 313 300 6.00% Senior Notes due 2020 - U.S. Dollar denominated 500 500 Principal Amount of Debt 4,606 4,266 Less: Debt Issuance Costs and Unamortized Discounts (69 ) (71 ) Total Debt $ 4,537 $ 4,195
Schedule of Maturities of Long-Term Debt	Scheduled principal payments due on the Company’s debt as of March 31, 2016 for the remainder of 2016 and thereafter were as follows: Year (in millions) 2016 2017 2018 2019 2020 Thereafter Total Debt $ 50 $ 95 $ 120 $ 1,080 $ 526 $ 2,735 $ 4,606

Pension and Postretirement Be29

Pension and Postretirement Benefits (Tables)	3 Months Ended
	Mar. 31, 2016
Compensation And Retirement Disclosure [Abstract]
Components of Net Periodic Benefit Cost	The following table summarizes the components of net periodic benefit cost for the Company’s pension benefits. Pension Benefits U.S. Plans Non-U.S. Plans Three Months Ended March 31, (in millions) 2016 2015 2016 2015 Service cost $ 3 $ 3 $ 2 $ 2 Interest cost 3 3 2 2 Expected return on plan assets (6 ) (6 ) (3 ) (3 ) Net periodic benefit cost $ — $ — $ 1 $ 1

Accumulated Other Comprehensi30

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2016
Accumulated Other Comprehensive Income Loss Net Of Tax [Abstract]
Summary of Changes in Components of AOCI, Net of Tax	The following table summarizes the changes in the components of AOCI, net of tax, for the periods indicated: (in millions) Cumulative Translation Adjustment Unrealized Gains (Losses) on Derivative Instruments Unamortized Pension and Other Benefits Adjustment Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2015 $ (287 ) $ (15 ) $ (48 ) $ (350 ) Other comprehensive income (loss) before reclassifications 71 (7 ) — 64 Amounts reclassified into earnings — (1 ) — (1 ) Other comprehensive income (loss) 71 (8 ) — 63 Balance, March 31, 2016 $ (216 ) $ (23 ) $ (48 ) $ (287 ) (in millions) Cumulative Translation Adjustment Unrealized Gains (Losses) on Derivative Instruments Unamortized Pension and Other Benefits Adjustment Accumulated Other Comprehensive Income (Loss) Balance, December 31, 2014 $ (169 ) $ (1 ) $ (47 ) $ (217 ) Other comprehensive income (loss) before reclassifications (77 ) 1 — (76 ) Amounts reclassified into earnings — (4 ) — (4 ) Other comprehensive income (loss) (77 ) (3 ) — (80 ) Balance, March 31, 2015 $ (246 ) $ (4 ) $ (47 ) $ (297 )

Operations by Business Segment

Operations by Business Segment (Tables)	3 Months Ended
	Mar. 31, 2016
Segment Reporting [Abstract]
Schedule of Geographic Information for Operating Regions	The following represents selected geographic information for the regions in which the Company operates. (in millions) Americas (1) EMEA (2) Asia Pacific (3) Corporate & Other Total Three Months Ended March 31, 2016 Revenue (4) $ 353 $ 307 $ 114 $ — $ 774 Operating income (loss) (5) 45 66 35 (33 ) 113 2015 Revenue (4) $ 294 $ 231 $ 107 $ — $ 632 Operating income (loss) (5) 67 58 39 (73 ) 91 In April 2015, the Company realigned its regional reporting so that India, Sri Lanka and Bangladesh are included in EMEA. Previously, these countries had been included in the Asia Pacific region. Additionally in 2015, the Company made changes to its geographic reporting classifications to move some functions out of Corporate and Other and into the regions. As a result of these changes, reclassifications of prior years’ geographic financial information were made to conform to the current year presentation. The reclassifications did not change previously reported condensed consolidated results of operations. (1) (2) (3) (4) (5) (in millions) Americas EMEA Asia Pacific Three Months Ended March 31, 2016 18 4 6 2015 27 14 8

Earnings per Share (Tables)

Earnings per Share (Tables)	3 Months Ended
	Mar. 31, 2016
Earnings Per Share [Abstract]
Composition of Basic and Diluted Weighted Average Shares Outstanding	The following table presents the composition of basic and diluted weighted average shares outstanding: Three Months Ended (Shares in millions) 2016 2015 Basic weighted-average common shares outstanding 328.6 335.5 Effect of dilutive stock-based awards 7.0 9.8 Diluted weighted-average common shares outstanding 335.6 345.3 Shares excluded from computation of diluted earnings per share: Weighted average potential common shares excluded from computation due to anti-dilutive effect 3.7 —

Basis of Presentation and Rec33

Basis of Presentation and Recently Issued Accounting Standards - Additional Information (Detail) - Country	12 Months Ended
	Dec. 31, 2015	Mar. 31, 2016
Outside United States | Geographic Concentration Risk | Revenue
Basis Of Presentation And Recent Accounting Pronouncements [Line Items]
Percentage of revenue generated from outside the United States	61.00%
Minimum
Basis Of Presentation And Recent Accounting Pronouncements [Line Items]
Number of countries in which the company transacts business	100	100

Acquisitions - Additional Infor

Acquisitions - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)Acquisition	Dec. 31, 2015USD ($)
Business Acquisition [Line Items]
Contingent consideration, minimum	$ 0
Contingent consideration, maximum	48
Contingent consideration, liability	$ 29	$ 28
Unrelated Individually Immaterial Acquisitions
Business Acquisition [Line Items]
Business acquisition, number of immaterial acquisitions | Acquisition	4

Acquisitions - Schedule of Fina

Acquisitions - Schedule of Financial Information Related to Acquisitions (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)
Business Acquisition [Line Items]
Total cost of acquisitions, net of cash acquired	$ 255
Acquisition-related costs	3
Amounts recorded in the Condensed Consolidated Statements of Financial Position:
Goodwill	177
Intangible assets	99
Computer software
Amounts recorded in the Condensed Consolidated Statements of Financial Position:
Computer software	$ 18
Client Relationships
Business Acquisition [Line Items]
Amortization Period	10 years
Amounts recorded in the Condensed Consolidated Statements of Financial Position:
Intangible assets	$ 67
Databases
Business Acquisition [Line Items]
Amortization Period	5 years
Amounts recorded in the Condensed Consolidated Statements of Financial Position:
Intangible assets	$ 28
Trade Names
Business Acquisition [Line Items]
Amortization Period	10 years
Amounts recorded in the Condensed Consolidated Statements of Financial Position:
Intangible assets	$ 4
Minimum | Computer software
Business Acquisition [Line Items]
Amortization Period	5 years
Maximum | Computer software
Business Acquisition [Line Items]
Amortization Period	10 years

Acquisitions - Schedule of Pro

Acquisitions - Schedule of Pro Forma Information (Detail) - Cegedim Acquisition $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2015USD ($)$ / shares
Business Acquisition [Line Items]
Revenues | $	$ 750
Net income | $	$ 300
Basic earnings per share | $ / shares	$ 0.89
Diluted earnings per share | $ / shares	$ 0.87

Goodwill - Summary of Changes i

Goodwill - Summary of Changes in Goodwill (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)
Goodwill Roll Forward
Beginning Balance	$ 3,604
Goodwill assigned in purchase price allocations	177
Foreign currency translation adjustments and other	63
Ending Balance	$ 3,844

Severance, Impairment and Oth38

Severance, Impairment and Other Charges - Schedule of Severance Related Reserves (Detail) - Severance $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)
2016 Plan
Restructuring Cost And Reserve [Line Items]
Charges	$ 15
Cash payments	(1)
Ending balance	14
2015 Plan
Restructuring Cost And Reserve [Line Items]
Beginning balance	51
Cash payments	(17)
Ending balance	$ 34

Severance, Impairment and Oth39

Severance, Impairment and Other Charges - Schedule of Severance Related Reserves (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
2016 Plan
Restructuring Cost And Reserve [Line Items]
Pre-tax severance charge	$ 15
2015 Plan
Restructuring Cost And Reserve [Line Items]
Pre-tax severance charge		$ 12	$ 64

Derivatives and Fair Value - Ad

Derivatives and Fair Value - Additional Information (Detail) € in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)Country	Mar. 31, 2015USD ($)	Mar. 31, 2016EUR (€)Country	Dec. 31, 2015USD ($)Country
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Total debt	$ 4,537			$ 4,195
Level 2
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Fair value of debt	4,613			$ 4,229
Net Investment Hedge
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Total debt	1,279		€ 1,123
Foreign exchange (loss) gain related to net investment hedge	$ (52)	$ 122
Minimum
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Number of countries in which the company transacts business | Country	100		100	100

Derivatives and Fair Value - Sc

Derivatives and Fair Value - Schedule of Components of Foreign Exchange Gain (Loss) (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Revaluation of other non-functional currency assets and liabilities	$ (7)
Effect of derivatives	3	$ 4
Total foreign exchange gain (loss)	$ (4)	$ 4

Derivatives and Fair Value - 42

Derivatives and Fair Value - Schedule of Components of Foreign Exchange Gain (Loss) (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
VENEZUELA
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Loss on Venezuela remeasurement	$ 1	$ 7

Derivatives and Fair Value - In

Derivatives and Fair Value - Interest Rate Risk Management - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2010
Interest Rate Swap | Designated as Hedging Instrument | Interest Rate Swap Agreements 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative basis spread on variable rate			1.00%
Foreign Exchange Contract
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Total derivatives not designated as hedging instruments	$ 1,000,000	$ (2,000,000)
Minimum | Designated as Hedging Instrument | Interest Rate Caps 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Strike rate			2.00%
Minimum | Interest Rate Cap | Designated as Hedging Instrument | Interest Rate Caps 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, maturity period	2017-04
Minimum | Interest Rate Swap | Designated as Hedging Instrument | Interest Rate Swap Agreements 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, maturity period	2017-03
Fixed interest payment rate			1.40%
Minimum | Interest Rate Swap | Not Designated as Hedging Instrument | Interest Rate Swap Agreements 2010
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Fixed interest payment rate				3.00%
Maximum
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Pre-tax unrealized losses on foreign currency derivatives expected to be reclassified during next 12 months	$ (15,000,000)
Maximum | Designated as Hedging Instrument | Interest Rate Caps 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Strike rate			3.00%
Maximum | Interest Rate Cap | Designated as Hedging Instrument | Interest Rate Caps 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, maturity period	2019-04
Derivative contract, period of effectiveness	2016-04
Maximum | Interest Rate Swap | Designated as Hedging Instrument | Interest Rate Swap Agreements 2014
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, maturity period	2021-03
Fixed interest payment rate			2.10%
Maximum | Interest Rate Swap | Not Designated as Hedging Instrument | Interest Rate Swap Agreements 2010
Derivative Instruments And Hedging Activities Disclosures [Line Items]
Derivative, maturity period	2016-01
Fixed interest payment rate				3.30%

Derivatives and Fair Value - 44

Derivatives and Fair Value - Schedule of Fair Value of Derivative Instruments (Detail) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Asset	$ 5	$ 11
Fair Value of Derivatives Liability	21	13
Designated as Hedging Instrument | Foreign Exchange Contract
Derivatives Fair Value [Line Items]
Derivative, nominal value	180	178
Designated as Hedging Instrument | Foreign Exchange Contract | Accounts receivable
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Asset	1	4
Designated as Hedging Instrument | Foreign Exchange Contract | Accounts payable
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability	8	2
Designated as Hedging Instrument | Interest Rate Cap
Derivatives Fair Value [Line Items]
Derivative, nominal value	1,000	1,000
Designated as Hedging Instrument | Interest Rate Cap | Other Assets
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Asset	1	4
Designated as Hedging Instrument | Interest Rate Swap
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability	13	10
Derivative, nominal value	530	517
Not Designated as Hedging Instrument | Foreign Exchange Contract
Derivatives Fair Value [Line Items]
Derivative, nominal value	150	148
Not Designated as Hedging Instrument | Foreign Exchange Contract | Accounts receivable
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Asset	$ 3	3
Not Designated as Hedging Instrument | Interest Rate Swap
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability		1
Derivative, nominal value		$ 100

Derivatives and Fair Value - 45

Derivatives and Fair Value - Schedule of Fair Value of Derivative Instruments (Parenthetical) (Detail) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability	$ 21	$ 13
Interest Rate Swap | Accrued And Other Current Liabilities
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability		1
Interest Rate Swap | Other Noncurrent Liabilities
Derivatives Fair Value [Line Items]
Fair Value of Derivatives Liability	$ 13	$ 10

Derivatives and Fair Value - 46

Derivatives and Fair Value - Schedule of Effect of Derivatives on Financial Performance (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Foreign Exchange Contract
Derivative Instruments Gain Loss [Line Items]
Amount of Income/(Loss) Recognized in AOCI	$ (8)	$ 7
Foreign Exchange Contract | Other Income (Loss), Net
Derivative Instruments Gain Loss [Line Items]
Amount of Income/(Loss) Reclassified from AOCI into Earnings	2	6
Interest Rate Derivatives
Derivative Instruments Gain Loss [Line Items]
Amount of Income/(Loss) Recognized in AOCI	$ (4)	$ (4)

Derivatives and Fair Value - 47

Derivatives and Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Assets
Derivatives assets	$ 5	$ 11
Liabilities
Contingent consideration, liability	29	28
Derivatives liabilities	21	13
Level 3
Liabilities
Contingent consideration, liability	29	28
Fair value measurements, recurring basis
Assets
Derivatives assets	5	11
Total assets	5	11
Liabilities
Contingent consideration, liability	29	28
Derivatives liabilities	21	13
Total liabilities	50	41
Fair value measurements, recurring basis | Level 2
Assets
Derivatives assets	5	11
Total assets	5	11
Liabilities
Derivatives liabilities	21	13
Total liabilities	21	13
Fair value measurements, recurring basis | Level 3
Liabilities
Contingent consideration, liability	29	28
Total liabilities	$ 29	$ 28

Derivatives and Fair Value - 48

Derivatives and Fair Value - Schedule of Level 3 Acquisition-Related Contingent Consideration Liabilities Carried at Fair Value on a Recurring Basis (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 28
Ending balance	29
Level 3
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	28
New acquisitions	2
Changes in fair value estimates and foreign currency translation adjustments	(1)
Ending balance	$ 29

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Detail) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Principal Amount of Debt	$ 4,606	$ 4,266
Less: Debt Issuance Costs and Unamortized Discounts	(69)	(71)
Total Debt	4,537	4,195
4.125% Senior Notes due 2023 | Euro denominated
Debt Instrument [Line Items]
Principal Amount of Debt	313	300
6.00% Senior Notes due 2020 | U.S. Dollar denominated
Debt Instrument [Line Items]
Principal Amount of Debt	500	500
USD LIBOR | Revolving Credit Facility due 2019 | U.S. Dollar denominated
Debt Instrument [Line Items]
Principal Amount of Debt	342	328
USD LIBOR | Secured Debt | Senior Secured Term A Loan due 2019
Debt Instrument [Line Items]
Principal Amount of Debt	766	484
USD LIBOR | Secured Debt | Senior Secured Term B Loan due 2021
Debt Instrument [Line Items]
Principal Amount of Debt	1,713	1,717
EUR LIBOR | Secured Debt | Senior Secured Term A Loan due 2019
Debt Instrument [Line Items]
Principal Amount of Debt	139	135
EUR LIBOR | Secured Debt | Senior Secured Term B Loan due 2021
Debt Instrument [Line Items]
Principal Amount of Debt	$ 833	$ 802

Debt - Schedule of Debt (Parent

Debt - Schedule of Debt (Parenthetical) (Detail)	3 Months Ended
	Mar. 31, 2016
Revolving Credit Facility due 2019
Debt Instrument [Line Items]
Debt instrument, maturity year	2,019
4.125% Senior Notes due 2023 | Euro denominated
Debt Instrument [Line Items]
Debt instrument, interest rate	4.125%
Debt instrument, maturity year	2,023
6.00% Senior Notes due 2020 | U.S. Dollar denominated
Debt Instrument [Line Items]
Debt instrument, interest rate	6.00%
Debt instrument, maturity year	2,020
USD LIBOR | Revolving Credit Facility due 2019 | U.S. Dollar denominated
Debt Instrument [Line Items]
Debt instrument, average floating rate	2.80%
USD LIBOR | Secured Debt | Senior Secured Term A Loan due 2019
Debt Instrument [Line Items]
Debt instrument, average floating rate	2.88%
Debt instrument, maturity year	2,019
USD LIBOR | Secured Debt | Senior Secured Term B Loan due 2021
Debt Instrument [Line Items]
Debt instrument, average floating rate	3.50%
Debt instrument, maturity year	2,021
EUR LIBOR | Secured Debt | Senior Secured Term A Loan due 2019
Debt Instrument [Line Items]
Debt instrument, average floating rate	2.25%
Debt instrument, maturity year	2,019
EUR LIBOR | Secured Debt | Senior Secured Term B Loan due 2021
Debt Instrument [Line Items]
Debt instrument, average floating rate	3.75%
Debt instrument, maturity year	2,021

Debt - Schedule of Maturities o

Debt - Schedule of Maturities of Long-Term Debt (Detail) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Long Term Debt By Maturity [Abstract]
Scheduled principal payments, 2016	$ 50
Scheduled principal payments, 2017	95
Scheduled principal payments, 2018	120
Scheduled principal payments, 2019	1,080
Scheduled principal payments, 2020	526
Scheduled principal payments, Thereafter	2,735
Total	$ 4,606	$ 4,266

Debt - Senior Secured Credit Fa

Debt - Senior Secured Credit Facilities - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2016	Jan. 31, 2016
Revolving Credit Facility
Debt Instrument [Line Items]
Line of credit facility, borrowing capacity	$ 500,000,000
Unused borrowing capacity	158,000,000
2016 Term Loan Amended
Debt Instrument [Line Items]
Additional borrowing capacity under Term A loans		$ 300,000,000
Debt amendment fees	2,000,000
2016 Term Loan Amended | Other Income (Loss), Net
Debt Instrument [Line Items]
Third party fees	1,000,000
2016 Term Loan Amended | Interest Expense
Debt Instrument [Line Items]
Third party fees	$ 1,000,000

Pension and Postretirement Be53

Pension and Postretirement Benefits - Components of Net Periodic Benefit Cost (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
US Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 3	$ 3
Interest cost	3	3
Expected return on plan assets	(6)	(6)
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	2	2
Interest cost	2	2
Expected return on plan assets	(3)	(3)
Net periodic benefit cost	$ 1	$ 1

Pension and Postretirement Be54

Pension and Postretirement Benefits - Additional Information (Detail) - Other Benefits - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Defined Benefit Plan Disclosure [Line Items]
Contribution made to plans	$ 6
Expected contribution for the remainder of 2016	5
Maximum
Defined Benefit Plan Disclosure [Line Items]
Postretirement benefit credit	$ 1	$ 1

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended
	Dec. 31, 2015	Mar. 31, 2016	Dec. 16, 2015
Equity [Abstract]
Amount authorized under common stock repurchase program			$ 250,000,000
Shares of common stock repurchased	670,000	0
Aggregate value of common stock repurchased	$ 17,000,000	$ 1,000,000
Average value per share of common stock repurchased	$ 25.70
Payments for repurchases stock		$ 3,000,000

Accumulated Other Comprehensi56

Accumulated Other Comprehensive Income (Loss) - Summary of Changes in Components of AOCI, Net of Tax (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	$ (350)	$ (217)
Other comprehensive income (loss) before reclassifications	64	(76)
Amounts reclassified into earnings	(1)	(4)
Other comprehensive income (loss), net of tax	63	(80)
Ending balance	(287)	(297)
Cumulative Translation Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(287)	(169)
Other comprehensive income (loss) before reclassifications	71	(77)
Other comprehensive income (loss), net of tax	71	(77)
Ending balance	(216)	(246)
Unrealized Gains (Losses) on Derivative Instruments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(15)	(1)
Other comprehensive income (loss) before reclassifications	(7)	1
Amounts reclassified into earnings	(1)	(4)
Other comprehensive income (loss), net of tax	(8)	(3)
Ending balance	(23)	(4)
Unamortized Pension and Other Benefits Adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	(48)	(47)
Ending balance	$ (48)	$ (47)

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)Country	Mar. 31, 2015USD ($)	Dec. 31, 2015Country
Income Tax [Line Items]
Provision for (benefit from) income taxes	$ 20	$ (240)
Reversal of deferred tax liability		$ 256
Minimum
Income Tax [Line Items]
Number of countries in which the company transacts business | Country	100		100

Contingencies - Additional Info

Contingencies - Additional Information (Detail) - SKI Contingency - USD ($) $ in Millions	Apr. 23, 2015	Sep. 30, 2014	Dec. 31, 2010	Dec. 31, 2008
Loss Contingencies [Line Items]
Contingency reserve				$ 4
Additional contingency reserve			$ 2
GSA settlement amount		$ 1.5
Settlement agreement payment	$ 1.5

Operations by Business Segmen59

Operations by Business Segment - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2016Segment
Segment Reporting [Abstract]
Number of operating segments	1
Number of reportable segments	1

Operations by Business Segmen60

Operations by Business Segment - Schedule of Geographic Information for Operating Regions (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Geographical Information [Line Items]
Revenue	$ 774	$ 632
Operating income (loss)	113	91
Americas
Geographical Information [Line Items]
Revenue	353	294
Operating income (loss)	45	67
EMEA
Geographical Information [Line Items]
Revenue	307	231
Operating income (loss)	66	58
Asia Pacific
Geographical Information [Line Items]
Revenue	114	107
Operating income (loss)	35	39
Corporate and Other
Geographical Information [Line Items]
Operating income (loss)	$ (33)	$ (73)

Operations by Business Segmen61

Operations by Business Segment - Schedule of Geographic Information for Operating Regions (Parenthetical) (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Geographical Information [Line Items]
Revenue	$ 774	$ 632
United States
Geographical Information [Line Items]
Revenue	305	245
Japan
Geographical Information [Line Items]
Revenue	64	64
Americas
Geographical Information [Line Items]
Revenue	353	294
Americas | Assets Recorded In Connection With Merger Transaction
Geographical Information [Line Items]
Depreciation and amortization expense	18	27
EMEA
Geographical Information [Line Items]
Revenue	307	231
EMEA | Assets Recorded In Connection With Merger Transaction
Geographical Information [Line Items]
Depreciation and amortization expense	4	14
Asia Pacific
Geographical Information [Line Items]
Revenue	114	107
Asia Pacific | Assets Recorded In Connection With Merger Transaction
Geographical Information [Line Items]
Depreciation and amortization expense	$ 6	$ 8

Earnings per Share - Compositio

Earnings per Share - Composition of Basic and Diluted Weighted Average Shares Outstanding (Detail) - shares shares in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Basic weighted-average common shares outstanding	328.6	335.5
Effect of dilutive stock-based awards	7	9.8
Diluted weighted-average common shares outstanding	335.6	345.3
Shares excluded from computation of diluted earnings per share:
Weighted average potential common shares excluded from computation due to anti-dilutive effect	3.7

Subsequent Events - Additional

Subsequent Events - Additional Information (Detail) - Quintiles I M S Holdings Inc - Subsequent Event	May. 03, 2016shares
Subsequent Event [Line Items]
IMS Health Holdings, Inc. ownership percentage	51.40%
Quintiles Transnational Holdings Inc, ownership percentage	48.60%
Common Stock
Subsequent Event [Line Items]
Exchange ratio under Merger agreement	0.3840